Potent anti-tumor immunity generated by a CD40-targeted adenoviral vaccine.

B.N. Hangalapura, D. Oosterhoff, J. de Groot, L. Boon, T. Tuting, A.J.M. van den Eertwegh, W.R. Gerritsen, V.W. van Beusechem, A. Pereboev, D.T. Curiel, R.J. Scheper, T.D. de Gruijl

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)5827-5837
JournalCancer Research
Volume71
Issue number17
DOIs
Publication statusPublished - 2011

Cite this